Scholar Rock is a biopharmaceutical company that discovers, develops, and delivers life-changing therapies for people with serious diseases that have high unmet need. As a global leader in the biology of the transforming growth factor beta (TGFβ) superfamily of cell proteins and named for the visual resemblance of a scholar rock to protein structures, the clinical-stage company is focused on advancing innovative treatments where protein growth factors are fundamental. Over the past decade, the company has created a pipeline with the potential to advance the standard of care for neuromuscular disease, cardiometabolic disorders, cancer, and other conditions where growth factor-targeted drugs can play a transformational role.
Scholar Rock is the only company to show clinical proof of concept for a muscle-targeted treatment in spinal muscular atrophy (SMA). This commitment to unlocking fundamentally different therapeutic approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity. By harnessing cutting-edge science in disease spaces that are historically under-addressed through traditional therapies, Scholar Rock works every day to create new possibilities for patients. Learn more about the company’s approach at ScholarRock.com and follow @ScholarRock and on LinkedIn.
Summary of Position:
Reporting to the VP, Commercial Finance and FP&A, the Senior Director, Financial Planning & Analysis (FP&A) will play a critical role in linking planned business activities with actual results. This individual will lead the day-to-day FP&A function, creating financial plans (annual budget and quarterly re-forecasts) and ensuring discipline and transparency in spend through insightful analysis and reporting. This dynamic role spans planning, financial analysis, decision support, accounting and reporting. The successful individual will have a deep understanding of financial analysis methods and approaches, US GAAP, financial processes (and systems) and advanced analytical capabilities that enable them to support the overall organization and Finance leadership. Scholar Rock is a growing organization, requiring a start-up mentality and an ability to work collaboratively to support all areas of the Business and Finance.
Scholar Rock is an Equal Opportunity Employer. We celebrate diversity and are committed to creating an inclusive environment for all employees.
If an employer mentions a salary or salary range on their job, we display it as an "Employer Estimate". If a job has no salary data, Rise displays an estimate if available.
As the Senior Director of Financial Planning & Analysis (FP&A) at Scholar Rock in Cambridge, MA, you will play an essential role in shaping the financial landscape of a pioneering biopharmaceutical company. Scholar Rock is dedicated to discovering and delivering life-changing therapies for serious diseases, and your expertise will ensure that their financial plans align seamlessly with business objectives. In this dynamic role, you'll lead a talented FP&A team, guiding them in creating annual budgets, conducting quarterly forecasts, and providing valuable insights that promote transparency in spending. Your analytical prowess will enable you to work closely with various stakeholders, enhancing collaborative efforts across different business areas. With a strong start-up mentality, you'll help cultivate a culture of excellence and innovation within the FP&A function, attracting top talent and fostering their development. If you're passionate about utilizing advanced financial analysis methods and enjoy working in a fast-paced environment that champions groundbreaking science, this position at Scholar Rock is your chance to make a significant impact while helping to transform the standard of care in biopharmaceuticals.
Relentlessly focused on seeing new possibilities in deep structural insights, validated biologies and antibody technologies to allow us to move with speed and urgency to deliver high-impact medicines to patients with devastating diseases.
18 jobsSubscribe to Rise newsletter